Abstract:Importance: While apathy and affective neuropsychiatric symptoms (NPS) are common in the clinical spectrum of Alzheimer's disease (AD), their neurobiological correlates remain unclear. Objective: To longitudinally examine plasma markers of neurodegeneration (neurofilament light chain; NfL) and tau pathology (phosphorylated at threonine 181; p-tau181) and their associations with apathy and affective symptoms in individuals with clinical diagnoses of AD dementia and mild cognitive impairment (MCI). Design, Setting, Participants and Exposure: This cohort study used longitudinal data from the Alzheimer Disease Neuroimaging Initiative (ADNI). Individuals with clinical diagnoses of MCI and AD dementia were enrolled in ADNI with serial annual blood samples over a four-year period, which were analyzed for NfL and p-tau181 using ultrasensitive techniques. Study data were accessed between July and September 2024. Main Outcomes and Measures: The presence of neuropsychiatric symptoms was determined using the Neuropsychiatric Interview (NPI). We analyzed the trajectory of plasma NfL and p-tau181 in each NPS using general linear mixed-effects models adjusted for age and sex. Results: There were 790 participants with AD dementia and MCI (mean [SD] age 72.7 [7.6] years; 333 females, 42%) and 417 healthy controls. The most common NPS was depression (n = 428; 54%), followed by irritability (n = 419; 53%), apathy (n = 348; 44%) and anxiety (n = 341; 43%). In the AD dementia and MCI group, apathy and anxiety were associated with higher levels of both NfL and p-tau181 after controlling for cognitive and functional decline. Moreover, apathy was associated with higher rate of NfL increase longitudinally. Depression at baseline was initially associated with higher NfL and p-tau181 levels, but this did not remain significant in the sensitivity analyses. Conclusion and Relevance: This study found that in individuals with clinical AD, apathy and anxiety are associated greater tau and neurodegenerative burden. Furthermore, those with apathy had a higher rate of NfL increase, which suggests an accelerated neurodegenerative process. These findings highlight that these symptoms be indicative of AD pathology severity and have implications for potential treatments which target tau pathology.

Neuroanatomical associations of depression, anxiety and apathy neuropsychiatric symptoms in patients with Alzheimer’s disease

Clinical and Neuroimaging Differences Between Posterior Cortical Atrophy and Typical Amnestic Alzheimer’s Disease Patients at an Early Disease Stage

Neurometabolic Characteristics in the Anterior Cingulate Gyrus of Alzheimer’s Disease Patients with Depression: a 1H Magnetic Resonance Spectroscopy Study

Altered Hippocampal Subfield Volumes in Major Depressive Disorder with and Without Anhedonia.

Gray Matter Volume Abnormalities in Depressive Patients with and Without Anxiety Disorders.

Regional Coherence Changes In Alzheimer'S Disease Patients With Depressive Symptoms: A Resting-State Functional Mri Study

The difference of gray matter volume and its correlation with clinical characteristics in patients with anxious depression

Clinical features and brain structural changes in magnetic resonance imaging in Alzheimer's disease patients with apathy

Abnormal Changes in Functional Connectivity Between the Amygdala and Frontal Regions Are Associated with Depression in Alzheimer’s Disease

Subregional Structural Alterations in Hippocampus and Nucleus Accumbens Correlate with the Clinical Impairment in Patients with Alzheimer’s Disease Clinical Spectrum: Parallel Combining Volume and Vertex-Based Approach

P1‐175: Neural Correlates of Depression in Subjects with Amnestic Mild Cognitive Impairment

Correlations of Apathy with Clinical Symptoms of Alzheimer’s Disease and Olfactory Dysfunctions: a Cross-Sectional Study

Asymmetric Differences in the Gray Matter Volume and Functional Connections of the Amygdala Are Associated With Clinical Manifestations of Alzheimer’s Disease

Gray matter abnormalities in patients with major depressive disorder and social anxiety disorder: a voxel-based meta-analysis

Gray Matter Structural Alterations in Social Anxiety Disorder: A Voxel-Based Meta-Analysis

Depression and Agitation Factors Are Related to Regional Brain Atrophy and Faster Longitudinal Cognitive Decline in Mild Cognitive Impairment

Longitudinal associations of apathy and regional tau in mild cognitive impairment and dementia: Findings from the Alzheimer's Disease Neuroimaging Initiative

Posterior Atrophy and Medial Temporal Atrophy Scores Are Associated with Different Symptoms in Patients with Alzheimer’s Disease and Mild Cognitive Impairment

Gray Matter Abnormalities in Non-comorbid Medication-naive Patients with Major Depressive Disorder or Social Anxiety Disorder

Apathy and Affective Symptoms Associated with Elevated Alzheimers Disease Biomarkers

Cortical thickness and subcortical structure volume abnormalities in patients with major depression with and without anxious symptoms.